HemaSphere (Aug 2023)

P387: THE TREATMENT RESPONSE OF A TWO-DOSE REGIMEN OF DOSE-ADJUSTED INOTUZUMAB IN RELAPSED/REFRACTORY B-ALL

  • Shuangyou Liu,
  • Lihong An,
  • Defeng Zhao,
  • Ruifeng Hou,
  • Yuehui Lin,
  • Huanhuan Guan,
  • Chunrong Tong,
  • Tong Wu

DOI
https://doi.org/10.1097/01.HS9.0000968456.74387.ea
Journal volume & issue
Vol. 7
p. e74387ea

Abstract

Read online

No abstracts available.